Sanofi India Limited — Updates, 02-08-2025: Press Release

Sanofi India reported a 9% net sales decline for the recent quarter, with year-to-date sales down 2%. Despite this, operating profit for the year-to-date period increased 6%, driven by cost optimization and operational efficiencies. Domestic growth was boosted by the successful Soliqua® launch and strong Toujeo® performance in diabetes. Strategic Cardiovascular and CNS partnerships are expanding market reach. Export sales were impacted by non-recurring past sales and the planned discontinuation of the Zentiva portfolio. The company continues its India strategy focusing on efficiency and innovation.